Literature DB >> 11672826

Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis.

R Quadri1, L Rubbia-Brandt, K Abid, F Negro.   

Abstract

The replication of hepatitis C virus (HCV) RNA is believed to occur via its transcription into a complementary, genomic-length RNA, the so-called negative-strand HCV RNA. This is based on the comparison with the replication of other members of the Flaviviridae family. Detection of the negative-strand HCV RNA in human tissues by semi-quantitative, strand-specific RT-PCR has contributed to the understanding of the HCV cell tropism and of the pathogenesis of HCV-associated disease manifestations. In particular, it was shown that the levels of intrahepatic HCV RNA are not correlated to the extent of the necroinflammation, but that a significant correlation was found with the liver steatosis. These results suggest that most liver disease associated with HCV infection is mediated by the host immune response. However, in some patients, most notably those infected with HCV genotype 3, HCV may cause a cytopathic effect, consisting in the lipid accumulation within hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672826     DOI: 10.1016/s0166-3542(01)00181-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  4 in total

1.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Steatosis and fibrosis in patients with chronic hepatitis C.

Authors:  J Wyatt; H Baker; P Prasad; Y Y Gong; C Millson
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

3.  The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Authors:  Hee Jae Jung; Young Seok Kim; Sang Gyune Kim; Yun Nah Lee; Soung Won Jeong; Jae Young Jang; Sae Hwan Lee; Hong Soo Kim; Boo Sung Kim
Journal:  Clin Mol Hepatol       Date:  2014-03-26

4.  Inhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formation.

Authors:  In-Woo Park; Jean Ndjomou; Yahong Wen; Ziqing Liu; Neale D Ridgway; C Cheng Kao; Johnny J He
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.